Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Sep 20, 2017 5:16pm
352 Views
Post# 26722410

Bullish technicals coinciding with good news

Bullish technicals coinciding with good news
The subtle and creeping uptick trend continued today in this very congested technical area of the one year and three year charts of PLI.  The 10day MAV continued its upward creep (1.44 ), towards the 50  day MAV at 1.47.  The $1.48 close today above the 50 day MAV is small but significant and continues to suggest net underlying buying interest,  and likely some further short covering.  A clear break above $1.47 on good volume along with the 10day MAV passing up thru the 50 will be a buy signal back up to the $1.67 area and the 90 day MAV....  above that its GAP time

I know the shorts want to keep everyone's focus on the Balance Sheet, but long term investors and industry are looking at the IP value build and risk reduction that came with this 4050 Alstrom efficacy,  which was nothing short of fantastic.  Smart money is watching and accumulating, and thats only going to ramp up further as FDA systematically continues to support PLI and is novel platform.  

PLI has SEVEN MONTHS of CASH
people will look back on all this hysteria and realize it was a great opportunity to either initiate or add to this story.  Ignore the noise

Bullboard Posts